Several studies using genome-wide molecular techniques have reported various degrees of genetic heterogeneity between primary tumours and their distant metastases. However, it has been difficult to discern patterns of dissemination owing to the limited number of patients and available metastases. Here, we use phylogenetic techniques on data generated using whole-exome sequencing and copy number profiling of primary and multiple-matched metastatic tumours from ten autopsied patients to infer the evolutionary history of breast cancer progression. We observed two modes of disease progression. In some patients, all distant metastases cluster on a branch separate from their primary lesion. Clonal frequency analyses of somatic mutations show that...
Defining the pathways through which tumors progress is critical to our understanding and treatment o...
Cancer results from alterations at essential genomic sites and is characterized by uncontrolled cell...
Breast cancer metastasis remains a clinical challenge, even within a single patient across multiple ...
Several studies using genome-wide molecular techniques have reported various degrees of genetic hete...
Several studies using genome-wide molecular techniques have reported various degrees of genetic hete...
Cancer related mortality is almost always due to metastatic dissemination of the primary disease. Wh...
With the rapid development of next-generation sequencing, deeper insights are being gained into the ...
Metastasis is the main cause of cancer patient deaths and remains a poorly characterized process. It...
BACKGROUND: In breast cancer (BC), axillary lymph node (ALN) involvement is one of the strongest adv...
Breast cancer is one of the leading causes of cancer mortality worldwide. Distant metastases are nea...
Patterns of genomic evolution between primary and metastatic breast cancer have not been studied in ...
Patterns of genomic evolution between primary and metastatic breast cancer have not been studied in ...
Cancers emerge from an ongoing Darwinian evolutionary process, often leading to multiple competing s...
Patterns of genomic evolution between primary and metastatic breast cancer have not been studied in ...
Melanoma is difficult to treat once it becomes metastatic. However, the precise ancestral relationsh...
Defining the pathways through which tumors progress is critical to our understanding and treatment o...
Cancer results from alterations at essential genomic sites and is characterized by uncontrolled cell...
Breast cancer metastasis remains a clinical challenge, even within a single patient across multiple ...
Several studies using genome-wide molecular techniques have reported various degrees of genetic hete...
Several studies using genome-wide molecular techniques have reported various degrees of genetic hete...
Cancer related mortality is almost always due to metastatic dissemination of the primary disease. Wh...
With the rapid development of next-generation sequencing, deeper insights are being gained into the ...
Metastasis is the main cause of cancer patient deaths and remains a poorly characterized process. It...
BACKGROUND: In breast cancer (BC), axillary lymph node (ALN) involvement is one of the strongest adv...
Breast cancer is one of the leading causes of cancer mortality worldwide. Distant metastases are nea...
Patterns of genomic evolution between primary and metastatic breast cancer have not been studied in ...
Patterns of genomic evolution between primary and metastatic breast cancer have not been studied in ...
Cancers emerge from an ongoing Darwinian evolutionary process, often leading to multiple competing s...
Patterns of genomic evolution between primary and metastatic breast cancer have not been studied in ...
Melanoma is difficult to treat once it becomes metastatic. However, the precise ancestral relationsh...
Defining the pathways through which tumors progress is critical to our understanding and treatment o...
Cancer results from alterations at essential genomic sites and is characterized by uncontrolled cell...
Breast cancer metastasis remains a clinical challenge, even within a single patient across multiple ...